Posted Feb. 27, 2013 at 10:34 a.m.

Premium Lock GSK joint venture strikes patent deal to lower HIV drug costs for children

Published: 2013-02-27 10:34:01
Updated: 2013-02-27 10:34:01

HIV AIDS research HIV AIDS research

ViiV Healthcare, a joint venture of GlaxoSmithKline and two other drugmakers, plans to license pediatric versions of its HIV drug abacavir to a patent-sharing body backed by the United Nations to improve children's access to treatment and lower costs....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Dr. Mike Walden
Tech economy
Scroll